254 related articles for article (PubMed ID: 37294262)
21. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
Kent CL; McDuff SGR; Salama JK
Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
[TBL] [Abstract][Full Text] [Related]
22. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.
Ashworth A; Rodrigues G; Boldt G; Palma D
Lung Cancer; 2013 Nov; 82(2):197-203. PubMed ID: 24051084
[TBL] [Abstract][Full Text] [Related]
23. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline.
Gondi V; Bauman G; Bradfield L; Burri SH; Cabrera AR; Cunningham DA; Eaton BR; Hattangadi-Gluth JA; Kim MM; Kotecha R; Kraemer L; Li J; Nagpal S; Rusthoven CG; Suh JH; Tomé WA; Wang TJC; Zimmer AS; Ziu M; Brown PD
Pract Radiat Oncol; 2022; 12(4):265-282. PubMed ID: 35534352
[TBL] [Abstract][Full Text] [Related]
24. Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.
Jairam V; Park HS; Decker RH
Cancer J; 2020; 26(2):129-136. PubMed ID: 32205537
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.
Kissel M; Martel-Lafay I; Lequesne J; Faivre JC; Le Péchoux C; Stefan D; Barraux V; Loiseau C; Grellard JM; Danhier S; Lerouge D; Chouaid C; Gervais R; Thariat J
BMC Cancer; 2019 Dec; 19(1):1237. PubMed ID: 31856742
[TBL] [Abstract][Full Text] [Related]
26. Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions.
Lang P; Gomez DR; Palma DA
Semin Respir Crit Care Med; 2020 Jun; 41(3):369-376. PubMed ID: 32450591
[TBL] [Abstract][Full Text] [Related]
27. Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer: Theory and Practice.
Rusthoven CG; Yeh N; Gaspar LE
Cancer J; 2015; 21(5):404-12. PubMed ID: 26389766
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
29. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer.
Guckenberger M; Andratschke N; Dieckmann K; Hoogeman MS; Hoyer M; Hurkmans C; Tanadini-Lang S; Lartigau E; Méndez Romero A; Senan S; Verellen D
Radiother Oncol; 2017 Jul; 124(1):11-17. PubMed ID: 28687397
[TBL] [Abstract][Full Text] [Related]
30. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
Guckenberger M; Belka C; Bezjak A; Bradley J; Daly ME; DeRuysscher D; Dziadziuszko R; Faivre-Finn C; Flentje M; Gore E; Higgins KA; Iyengar P; Kavanagh BD; Kumar S; Le Pechoux C; Lievens Y; Lindberg K; McDonald F; Ramella S; Rengan R; Ricardi U; Rimner A; Rodrigues GB; Schild SE; Senan S; Simone CB 2nd; Slotman BJ; Stuschke M; Videtic G; Widder J; Yom SS; Palma D
Radiother Oncol; 2020 May; 146():223-229. PubMed ID: 32342863
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Smith BD; Bellon JR; Blitzblau R; Freedman G; Haffty B; Hahn C; Halberg F; Hoffman K; Horst K; Moran J; Patton C; Perlmutter J; Warren L; Whelan T; Wright JL; Jagsi R
Pract Radiat Oncol; 2018; 8(3):145-152. PubMed ID: 29545124
[TBL] [Abstract][Full Text] [Related]
32. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
34. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
Leduc C; Antoni D; Quoix É; Noël G
Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
[TBL] [Abstract][Full Text] [Related]
35. Robot-assisted Extracranial Stereotactic Radiotherapy of Adrenal Metastases in Oligometastatic Non-small Cell Lung Cancer.
Celik E; Semrau R; Baues C; Trommer-Nestler M; Baus W; Marnitz S
Anticancer Res; 2017 Sep; 37(9):5285-5291. PubMed ID: 28870966
[TBL] [Abstract][Full Text] [Related]
36. Changing equipoise in the landscape of radiation for oligometastatic lung cancer.
Schroeder SR; Leenders M; Iyengar P; de Ruysscher D
Transl Lung Cancer Res; 2019 Sep; 8(Suppl 2):S184-S191. PubMed ID: 31673523
[TBL] [Abstract][Full Text] [Related]
37. Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1-5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial.
Tibdewal A; Agarwal JP; Srinivasan S; Mummudi N; Noronha V; Prabhash K; Patil V; Purandare N; Janu A; Kannan S
BMJ Open; 2021 Mar; 11(3):e043628. PubMed ID: 33727268
[TBL] [Abstract][Full Text] [Related]
38. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
39. [Radiotherapy for oligometastatic non-small cell lung cancer patients].
Levy A; Roux C; Mercier O; Issard J; Botticella A; Barlesi F; Le Péchoux C
Cancer Radiother; 2021 Oct; 25(6-7):517-522. PubMed ID: 34175225
[TBL] [Abstract][Full Text] [Related]
40. The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
Expert Rev Anticancer Ther; 2015; 15(12):1459-71. PubMed ID: 26536370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]